Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.2M Sell
461,393
-77,480
-14% -$3.96M 2.18% 12
2026
Q2
$28.2M Sell
538,873
-2,880
-0.5% -$152K 3.05% 10
2026
Q1
$29.9M Sell
541,753
-36,639
-6% -$1.99M 3.97% 6
2025
Q4
$28.4M Buy
578,392
+501,590
+653% +$23.4M 2.66% 8
2025
Q3
$3.31M Buy
+76,802
New +$3M 0.33% 66

Other funds holding GSK

ABC Arbitrage's GSK Position: Q3 2026 in Review

ABC Arbitrage reduced its GSK (GSK) stake by 14% in Q3 2026, selling an estimated $3.96M and leaving 461,393 shares worth $22.2M. The position accounts for 2.18% of the portfolio, ranked #12.

ABC Arbitrage first reported a position in GSK in Q3 2025 and has held it in 5 quarters since. The position peaked at $29.9M in Q1 2026. 307 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • ABC Arbitrage held 461,393 shares of GSK worth $22.2M as of Q3 2026.
  • ABC Arbitrage sold 77,480 GSK shares in Q3 2026, an estimated $3.96M.
  • GSK made up 2.18% of ABC Arbitrage's portfolio in Q3 2026, its #12 holding.
  • ABC Arbitrage first reported a position in GSK in Q3 2025 and has held it in 5 quarters since.
  • ABC Arbitrage's GSK position peaked at $29.9M in Q1 2026.
  • 307 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on ABC Arbitrage's 13F filing for Q3 2026, filed 23 Oct 2026.